NDXP241122P19475000
- 2.23
- 0.000.00%
NASDAQ 100 Index Newsroom
Trump Picks Scott Bessent as Treasury Secretary, What Does It Mean for the Financial Markets?
Wolfe's Most Shorted 'Hit List' – FSLR, BE, WBA, SJM
Nvidia Blackwell Supplier Vishay Intertechnology Likey To See Upside Courtesy Of AI Frenzy: Analyst
Amgen's weight loss drug has a remarkable 20% reduction effect, but with high side effects, causing the stock price to plummet by 12.3% at one point!
Although the weight loss effect of amgen's MariTide drug met expectations, the high side effects, lower than eli lilly and co's Zepbound, and the trial results falling below Wall Street's high expectations, led to amgen's stock price plunging over 12.3% on Tuesday, far behind eli lilly and co and novo-nordisk a/s, which benefited from the Biden policy rise at the same time. In a one-year trial, MariTide helped non-diabetic patients lose up to 20% of their weight, comparable to the maximum dose effect of eli lilly's Zepbound. However, the side effects are significant, with about 11% of patients dropping out of the trial due to side effects, higher than eli lilly's 7%.
Stocks Mixed Ahead Of Fed Minutes, Mexican Peso Tumbles To Over 2-Year Lows On Tariffs Fears: What's Driving Markets Tuesday?
Unpacking the Latest Options Trading Trends in Intuitive Surgical
Bird Flu Found In Raw Milk Leads To Recall In California
Dyne, Avidity Initiated at Outperform by RBC on DM1 Drugs
Unveiling 12 Analyst Insights On Charter Communications
Unpacking the Latest Options Trading Trends in Workday
Charter Communications Analyst Ratings
Analog Devices, Inc. (ADI) Q4 2024 Earnings Call Transcript Summary
10 Consumer Discretionary Stocks Whale Activity In Today's Session
10 Information Technology Stocks Whale Activity In Today's Session
Amazon Dominates Holiday Shopping As Black Friday Spending Soars: Goldman Sachs
Pubmatic Forges Partnership With Intuit SMB Medialabs To Advance B2B Advertising With Privacy-Protective Solutions
Decoding Adobe's Options Activity: What's the Big Picture?
Check Out What Whales Are Doing With AMAT
Amgen Decline on MariTide Data Could Be Due to Lack of More Details
Intuitive Surgical Analyst Ratings